We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

150 hedge funds and large institutions have $599M invested in Dynavax Technologies in 2018 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 46 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 46

3% less funds holding

Funds holding: 155150 (-5)

5.02% less ownership

Funds ownership: 82.16%77.14% (-5%)

19% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 21

22% less capital invested

Capital invested by funds: $769M → $599M (-$170M)

46% less call options, than puts

Call options by funds: $5.91M | Put options by funds: $11M

Holders
150
Holders Change
-5
Holders Change %
-3.23%
% of All Funds
3.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
46
Reduced
46
Closed
21
Calls
$5.91M
Puts
$11M
Net Calls
-$5.05M
Net Calls Change
-$6.04M
Name Holding Trade Value Shares
Change
Change in
Stake
State Street
1
State Street
Massachusetts
$52.1M -$17.2M -1,269,332 -23%
BlackRock
2
BlackRock
New York
$51.1M +$765K +56,568 +1%
Franklin Resources
3
Franklin Resources
California
$38.9M +$3.25M +239,876 +8%
HM
4
HealthCor Management
New York
$38.7M +$7.99M +590,362 +23%
Vanguard Group
5
Vanguard Group
Pennsylvania
$35.8M +$404K +29,898 +1%
SM
6
Senvest Management
New York
$31.2M +$2.48M +183,023 +8%
EAM
7
Eagle Asset Management
Florida
$28.5M -$45.3K -3,351 -0.1%
CC
8
Chicago Capital
Illinois
$27.9M +$13M +957,942 +74%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$26.1M +$3.99M +294,790 +16%
CTA
10
Carillon Tower Advisers
Florida
$20.3M
Federated Hermes
11
Federated Hermes
Pennsylvania
$19.8M -$792K -58,523 -4%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$18.3M -$2.19M -161,800 -10%
PC
13
PointState Capital
New York
$16.3M -$7.73M -571,700 -30%
FCM
14
Farallon Capital Management
California
$13.3M -$5.01M -370,000 -26%
William Blair & Company
15
William Blair & Company
Illinois
$11.3M +$151K +11,187 +1%
ClearBridge Investments
16
ClearBridge Investments
New York
$11.2M +$12.2M +904,057 +1,189,549%
Citadel Advisors
17
Citadel Advisors
Florida
$10.8M +$10.4M +769,376 +755%
Northern Trust
18
Northern Trust
Illinois
$9.81M +$546K +40,333 +5%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$7.36M +$552K +40,827 +7%
UBS AM
20
UBS AM
Illinois
$6.85M -$475K -35,135 -6%
FLAM
21
First Light Asset Management
Minnesota
$6.77M -$34K -2,512 -0.5%
CWG
22
C WorldWide Group
Denmark
$6.77M -$3.37M -249,032 -31%
Morgan Stanley
23
Morgan Stanley
New York
$6.39M -$556K -41,122 -7%
Deutsche Bank
24
Deutsche Bank
Germany
$6.14M +$2.65M +195,632 +65%
Ameriprise
25
Ameriprise
Minnesota
$6.08M +$1.51M +111,780 +30%

DVAX Hedge Fund Activity: Q3 2018 in Review

150 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q3 2018, worth a combined $599M — down 22% from $769M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of DVAX and 17 opened new positions — a net loss of 4 holders — while 46 trimmed existing stakes and 46 added.

The largest buyer was Chicago Capital, adding an estimated $13M. The largest seller was Point72 Asset Management, cutting an estimated $17.7M.

  • 150 institutional investors held Dynavax Technologies (DVAX) as of Q3 2018, down from 155 in Q2 2018.
  • Funds reported $599M of Dynavax Technologies stock for Q3 2018, down 22% quarter-over-quarter.
  • 17 funds opened new Dynavax Technologies positions in Q3 2018 and 21 closed out, a net change of -4 holders.
  • The largest Dynavax Technologies buyer in Q3 2018 was Chicago Capital, an estimated $13M added.
  • The largest Dynavax Technologies seller in Q3 2018 was Point72 Asset Management, an estimated $17.7M sold.

Based on aggregated 13F filings for Q3 2018.